103 related articles for article (PubMed ID: 19660595)
1. Association of leukocyte subtype counts with coronary atherosclerotic regression following pravastatin treatment.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
Am J Cardiol; 2009 Aug; 104(4):464-9. PubMed ID: 19660595
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
3. Development of a model for prediction of coronary atherosclerotic regression: evaluation of high-density lipoprotein cholesterol level and peripheral blood monocyte count.
Tani S; Matsumoto M; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Washio T; Kumabe N; Kobori M; Nagao K; Hirayama A
Heart Vessels; 2012 Mar; 27(2):143-50. PubMed ID: 21416115
[TBL] [Abstract][Full Text] [Related]
4. Association of circulating leukocyte count with coronary atherosclerosis regression after pravastatin treatment.
Tani S; Nagao K; Anazawa T; Kawamata H; Iida K; Matsumoto M; Sato Y; Hirayama A
Atherosclerosis; 2008 Jun; 198(2):360-5. PubMed ID: 18374337
[TBL] [Abstract][Full Text] [Related]
5. Relation of change in apolipoprotein B/apolipoprotein A-I ratio to coronary plaque regression after Pravastatin treatment in patients with coronary artery disease.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
Am J Cardiol; 2010 Jan; 105(2):144-8. PubMed ID: 20102908
[TBL] [Abstract][Full Text] [Related]
6. Effect of pravastatin on coronary plaque volume.
Ishikawa K; Tani S; Watanabe I; Matsumoto M; Furukawa K; Nomoto K; Nomoto K; Kushiro T; Nagao K; Kanmatsuse K
Am J Cardiol; 2003 Oct; 92(8):975-7. PubMed ID: 14556877
[TBL] [Abstract][Full Text] [Related]
7. Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis.
Nozue T; Yamamoto S; Tohyama S; Umezawa S; Kunishima T; Sato A; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Sozu T; Terashima M; Michishita I
Am Heart J; 2012 Feb; 163(2):191-9.e1. PubMed ID: 22305836
[TBL] [Abstract][Full Text] [Related]
8. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
[TBL] [Abstract][Full Text] [Related]
9. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
[TBL] [Abstract][Full Text] [Related]
10. Association of body mass index with coronary plaque regression: 6-month prospective study.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
J Atheroscler Thromb; 2009 Jun; 16(3):275-82. PubMed ID: 19556715
[TBL] [Abstract][Full Text] [Related]
11. Comparison of effects of serum n-3 to n-6 polyunsaturated fatty acid ratios on coronary atherosclerosis in patients treated with pitavastatin or pravastatin undergoing percutaneous coronary intervention.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I
Am J Cardiol; 2013 Jun; 111(11):1570-5. PubMed ID: 23497779
[TBL] [Abstract][Full Text] [Related]
12. Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound.
von Birgelen C; Hartmann M; Mintz GS; Baumgart D; Schmermund A; Erbel R
Circulation; 2003 Dec; 108(22):2757-62. PubMed ID: 14623804
[TBL] [Abstract][Full Text] [Related]
13. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.
Nasu K; Tsuchikane E; Katoh O; Tanaka N; Kimura M; Ehara M; Kinoshita Y; Matsubara T; Matsuo H; Asakura K; Asakura Y; Terashima M; Takayama T; Honye J; Hirayama A; Saito S; Suzuki T
JACC Cardiovasc Interv; 2009 Jul; 2(7):689-96. PubMed ID: 19628194
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
[TBL] [Abstract][Full Text] [Related]
15. Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] study).
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I;
Am J Cardiol; 2013 Apr; 111(7):923-9. PubMed ID: 23337838
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease.
Watanabe K; Sugiyama S; Kugiyama K; Honda O; Fukushima H; Koga H; Horibata Y; Hirai T; Sakamoto T; Yoshimura M; Yamashita Y; Ogawa H
J Am Coll Cardiol; 2005 Dec; 46(11):2022-30. PubMed ID: 16325036
[TBL] [Abstract][Full Text] [Related]
17. Effects of serum n-3 to n-6 polyunsaturated fatty acids ratios on coronary atherosclerosis in statin-treated patients with coronary artery disease.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I
Am J Cardiol; 2013 Jan; 111(1):6-11. PubMed ID: 23040588
[TBL] [Abstract][Full Text] [Related]
18. Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound.
Tardif JC; Grégoire J; L'Allier PL; Ibrahim R; Lavoie MA; LeMay M; Cohen E; Levesque S; Keller PF; Heinonen T; Guertin MC
Am J Cardiol; 2006 Jul; 98(1):23-7. PubMed ID: 16784914
[TBL] [Abstract][Full Text] [Related]
19. Coronary plaque regression and lifestyle modification in patients treated with pravastatin. - Assessment mainly by daily aerobic exercise and an increase in the serum level of high-density lipoprotein cholesterol -.
Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Takahashi H; Iida K; Matsumoto M; Washio T; Kumabe N; Hirayama A
Circ J; 2010 May; 74(5):954-61. PubMed ID: 20234098
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein and future cardiovascular events in statin-treated patients with angina pectoris: the extended TRUTH study.
Nozue T; Fukui K; Yamamoto S; Kunishima T; Umezawa S; Onishi Y; Tohyama S; Takeyama Y; Morino Y; Yamauchi T; Hibi K; Sozu T; Terashima M; Michishita I;
J Atheroscler Thromb; 2013; 20(9):717-25. PubMed ID: 23748166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
